Deutsche Bank
ADPT icon

Deutsche Bank’s Adaptive Biotechnologies ADPT Stock Holding History

Deutsche Bank’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.09M Sell
237,406
-548,377
-70% -$8.4M ﹤0.01% 1366
2026
Q1 		$10.9M Sell
785,783
-948,682
-55% -$15.1M ﹤0.01% 1026
2025
Q4 		$28.2M Buy
1,734,465
+21,326
+1% +$348K 0.01% 789
2025
Q3 		$25.6M Buy
1,713,139
+1,542,685
+905% +$18.8M 0.01% 784
2025
Q2 		$1.99M Sell
170,454
-447,721
-72% -$4.07M ﹤0.01% 1713
2025
Q1 		$4.59M Sell
618,175
-12,402
-2% -$95.3K ﹤0.01% 1286
2024
Q4 		$3.78M Buy
630,577
+503,842
+398% +$2.78M ﹤0.01% 1477
2024
Q3 		$649K Sell
126,735
-458,968
-78% -$2M ﹤0.01% 2321
2024
Q2 		$2.12M Sell
585,703
-18,803
-3% -$59.7K ﹤0.01% 1605
2024
Q1 		$1.94M Buy
604,506
+1,450
+0.2% +$5.61K ﹤0.01% 1678
2023
Q4 		$2.95M Buy
603,056
+546,069
+958% +$2.49M ﹤0.01% 1480
2023
Q3 		$311K Sell
56,987
-540,190
-90% -$3.57M ﹤0.01% 2490
2023
Q2 		$4.01M Sell
597,177
-37,886
-6% -$282K ﹤0.01% 1322
2023
Q1 		$5.61M Buy
635,063
+12,345
+2% +$109K ﹤0.01% 1197
2022
Q4 		$4.76M Sell
622,718
-31,335
-5% -$244K ﹤0.01% 1235
2022
Q3 		$4.66M Buy
654,053
+5,651
+0.9% +$53.2K ﹤0.01% 1240
2022
Q2 		$5.25M Buy
648,402
+306,982
+90% +$2.7M ﹤0.01% 1258
2022
Q1 		$4.74M Buy
341,420
+206,421
+153% +$3.25M ﹤0.01% 1450
2021
Q4 		$3.79M Sell
134,999
-22,012
-14% -$675K ﹤0.01% 1605
2021
Q3 		$5.34M Buy
157,011
+10,922
+7% +$395K ﹤0.01% 1469
2021
Q2 		$5.97M Sell
146,089
-18,711
-11% -$727K ﹤0.01% 1420
2021
Q1 		$6.63M Buy
164,800
+125,067
+315% +$6.77M ﹤0.01% 1401
2020
Q4 		$2.35M Sell
39,733
-113,601
-74% -$5.86M ﹤0.01% 1831
2020
Q3 		$7.46M Buy
153,334
+107,309
+233% +$4.51M 0.01% 1085
2020
Q2 		$2.23M Sell
46,025
-359,678
-89% -$13.1M ﹤0.01% 1734
2020
Q1 		$11.3M Buy
405,703
+384,326
+1,798% +$10.7M 0.01% 871
2019
Q4 		$637K Buy
21,377
+13,750
+180% +$395K ﹤0.01% 2609
2019
Q3 		$235K Buy
+7,627
New +$311K ﹤0.01% 3093

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Deutsche Bank's ADPT Position: Q2 2026 in Review

Deutsche Bank reduced its Adaptive Biotechnologies (ADPT) stake by 70% in Q2 2026, selling an estimated $8.4M and leaving 237,406 shares worth $5.09M. The position accounts for ﹤0.01% of the portfolio, ranked #1366.

Deutsche Bank first reported a position in ADPT in Q3 2019 and has held it in 28 quarters since. The position peaked at $28.2M in Q4 2025. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Deutsche Bank held 237,406 shares of Adaptive Biotechnologies worth $5.09M as of Q2 2026.
  • Deutsche Bank sold 548,377 Adaptive Biotechnologies shares in Q2 2026, an estimated $8.4M.
  • Adaptive Biotechnologies made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #1366 holding.
  • Deutsche Bank first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 28 quarters since.
  • Deutsche Bank's Adaptive Biotechnologies position peaked at $28.2M in Q4 2025.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.